Literature DB >> 23797316

Racial/Ethnic and regional differences in the prevalence of inflammatory bowel disease in the United States.

Yize R Wang1, Edward V Loftus, John R Cangemi, Michael F Picco.   

Abstract

BACKGROUND: The magnitude of racial/ethnic and regional differences in the prevalence of inflammatory bowel disease (IBD) in the United States remains largely unknown. AIMS: To estimate differences in the prevalence of IBD by race/ethnicity and region.
METHODS: The Medical Expenditure Panel Survey, a nationally representative survey of US households and medical conditions, was used. A multivariate logistic model was used in statistical analysis.
RESULTS: Among 202,468 individuals surveyed during 1996-2007, 316 were diagnosed with IBD (26 Blacks, 21 Hispanics, and 5 Asians). The prevalence of IBD was higher in Whites [Crohn's disease: 154; ulcerative colitis (UC): 89] than Blacks (Crohn's disease: 68; UC: 25), Hispanics (Crohn's disease: 15; UC: 35), and Asians (Crohn's: 45; UC: 40) (all p < 0.05, except for UC in Asians). The differences in Crohn's disease between Whites and minorities and the difference in UC between Whites and Blacks remained significant in multivariate analysis. In multivariate analysis, there was no regional difference in the prevalence of Crohn's disease, but the prevalence of UC was higher in the Northeast than the South (p < 0.05).
CONCLUSIONS: There were significant racial/ethnic differences in the prevalence of IBD in the USA. The underlying etiology of these differences warrants additional research.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23797316     DOI: 10.1159/000350759

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  12 in total

1.  Characterization of genetic loci that affect susceptibility to inflammatory bowel diseases in African Americans.

Authors:  Chengrui Huang; Talin Haritunians; David T Okou; Dermot P B McGovern; Steven R Brant; Subra Kugathasan; David J Cutler; Michael E Zwick; Kent D Taylor; Lisa W Datta; Joseph C Maranville; Zhenqiu Liu; Shannon Ellis; Pankaj Chopra; Jonathan S Alexander; Robert N Baldassano; Raymond K Cross; Themistocles Dassopoulos; Tanvi A Dhere; Richard H Duerr; John S Hanson; Jason K Hou; Sunny Z Hussain; Kim L Isaacs; Kelly E Kachelries; Howard Kader; Michael D Kappelman; Jeffrey Katz; Richard Kellermayer; Barbara S Kirschner; John F Kuemmerle; Archana Kumar; John H Kwon; Mark Lazarev; Peter Mannon; Dedrick E Moulton; Bankole O Osuntokun; Ashish Patel; John D Rioux; Jerome I Rotter; Shehzad Saeed; Ellen J Scherl; Mark S Silverberg; Ann Silverman; Stephan R Targan; John F Valentine; Ming-Hsi Wang; Claire L Simpson; S Louis Bridges; Robert P Kimberly; Stephen S Rich; Judy H Cho; Anna Di Rienzo; Linda W H Kao
Journal:  Gastroenterology       Date:  2015-08-14       Impact factor: 22.682

2.  Harnessing person-generated health data to accelerate patient-centered outcomes research: the Crohn's and Colitis Foundation of America PCORnet Patient Powered Research Network (CCFA Partners).

Authors:  Arlene E Chung; Robert S Sandler; Millie D Long; Sean Ahrens; Jessica L Burris; Christopher F Martin; Kristen Anton; Amber Robb; Thomas P Caruso; Elizabeth L Jaeger; Wenli Chen; Marshall Clark; Kelly Myers; Angela Dobes; Michael D Kappelman
Journal:  J Am Med Inform Assoc       Date:  2016-01-28       Impact factor: 4.497

3.  Update on the Incidence and Prevalence of Inflammatory Bowel Disease in the United States.

Authors:  Edward V Loftus
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

4.  Patient-reported outcomes in Crohn's disease: does race matter?

Authors:  Sara Horst
Journal:  Dig Dis Sci       Date:  2014-08-12       Impact factor: 3.199

5.  Management of inflammatory bowel disease with oral serum-derived bovine immunoglobulin.

Authors:  Ira Shafran; Patricia Burgunder; David Wei; Hayley E Young; Gerald Klein; Bruce P Burnett
Journal:  Therap Adv Gastroenterol       Date:  2015-11       Impact factor: 4.409

6.  Ethnic differences in inflammatory bowel disease: Results from the United Kingdom inception cohort epidemiology study.

Authors:  Ravi Misra; Jimmy Limdi; Rachel Cooney; Samia Sakuma; Matthew Brookes; Edward Fogden; Sanjeev Pattni; Naveen Sharma; Tariq Iqbal; Pia Munkholm; Johan Burisch; Naila Arebi
Journal:  World J Gastroenterol       Date:  2019-10-28       Impact factor: 5.742

7.  Prevalence of Fistulizing Crohn's Disease in the United States: Estimate From a Systematic Literature Review Attempt and Population-Based Database Analysis.

Authors:  David A Schwartz; Ignacio Tagarro; Mary Carmen Díez; William J Sandborn
Journal:  Inflamm Bowel Dis       Date:  2019-10-18       Impact factor: 5.325

8.  Quantitative Analysis of Intestinal Flora of Uygur and Han Ethnic Chinese Patients with Ulcerative Colitis.

Authors:  Ping Yao; Min Cui; Haikun Wang; Hongliang Gao; Lei Wang; Tao Yang; Yongbo Cheng
Journal:  Gastroenterol Res Pract       Date:  2015-12-29       Impact factor: 2.260

9.  Epidemiology of inflammatory bowel disease in racial and ethnic migrant groups.

Authors:  Ravi Misra; Omar Faiz; Pia Munkholm; Johan Burisch; Naila Arebi
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

10.  Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010.

Authors:  Satimai Aniwan; W Scott Harmsen; William J Tremaine; Edward V Loftus
Journal:  Therap Adv Gastroenterol       Date:  2019-02-06       Impact factor: 4.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.